Managing medicines in the time of COVID-19: implications for community-dwelling people with dementia

Barry, Heather E.; Hughes, Carmel

doi:10.1007/s11096-020-01116-y

Cited by 15 publications

(26 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A number of research papers focused on the diminishing sources of support in the first wave of the pandemic, and the challenges faced by carers. In the United Kingdom (UK), Barry and Hughes [21] appealed for support for family carers and healthcare professionals treating older people with dementia, as they have a critical role in the management of medicine intake. In Austria, due to a reduction in available therapies and support (e.g., rehabilitative) services for older people in need of care, symptoms of people cared for (including those with dementia) worsened, leading to an increased burden for family carers [22].…”

Section: Changes Brought On By the Covid-19 Pandemicmentioning

confidence: 99%

Impact of the COVID-19 Pandemic on Family Carers of Older People Living with Dementia in Italy and Hungary

Kostyál

Széman

Almási³

et al. 2021

Sustainability

View full text Add to dashboard Cite

The COVID-19 pandemic has had a major effect on both older people with dementia and families caring for them. This paper presents the results of an online survey carried out among Italian and Hungarian family carers of people with dementia during the first pandemic wave (May–July 2020, n = 370). The research questions were the following: (1) How has the pandemic changed the lives of family carers? (2) How did government restriction measures change the availability of care-related help? (3) What other changes did families experience? Results show that about one-quarter of both subsamples experienced a deterioration in their financial status. A decline in both general and mental health was also reported. Due to “lockdown”, family carers’ burden increased substantially. Utilization of care-related help decreased, and the share of those left with no help increased in both countries. Cross-country differences emerged in terms of dementia care system, severity of the first pandemic wave, and measures put in place by governments. Findings outline the weaknesses of support structures and their country-specific vulnerabilities to a worldwide pandemic. To better protect people with dementia in the future, it is essential to strengthen their family carers, and support structures need to be re-evaluated and re-designed.

show abstract

Section: Changes Brought On By the Covid-19 Pandemicmentioning

confidence: 99%

Impact of the COVID-19 Pandemic on Family Carers of Older People Living with Dementia in Italy and Hungary

Kostyál

Széman

Almási³

et al. 2021

Sustainability

View full text Add to dashboard Cite

show abstract

“…For people living with disabilities, these circumstances created collateral damage in terms of access to health care services, including rehabilitation [65]. This means that chronic neurological patients receive less attention and care than before [66]. On the other hand, the total number of neuro-emergencies has fallen significantly since the onset of the pandemic [67,68].…”

Section: Other Considerationsmentioning

confidence: 99%

Neurological impairments in COVID-19 pandemic

Bjelobaba¹,

Kanazir²

2020

Hrana i ishrana

View full text Add to dashboard Cite

The growing body of data implies that SARS-CoV-2 infection may affect the nervous system. We here present a short, taciturn overview of described neurological impairments related to SARS-CoV-2 infection. While it is obvious that neurological impairments can be diagnosed in a portion of COVID-19 patients, evidence of SARS-CoV-2 neurovirulence in humans is still lacking. The existing data on the incidence of neurological impairments among COVID-19 patients is highly variable, probably because they (most often) come from small, single-center retrospective studies. These data are practically published in real-time, and the question remains when larger studies will be available, given that the pandemic is continuing. We here also shortly address the other issues related to neurological disorders and COVID-19 pandemic, including the concern for people with existing chronic neurological disorders and possible long-term neurological consequences of SARS-CoV-2 infection.

show abstract

“…Although most people contracting the virus experience mild/moderate symptoms that dissipate without treatment, more vulnerable individuals (e.g., elderly populations with health comorbidities, psychiatric populations) may develop severe complications that can lead to hospitalization, intubation, and/or death [ 1 ]. To slow down the propagation of the virus, strict confinement measures and limited social contacts have had to be deployed [ 2 ]. Although contexts differ substantially, a parallel may be drawn between this situation and solitary confinement in correctional settings that consist of placing inmates in restricted housing with increased security for a prolonged amount of time, often for up to 23 hours per day, with strictly limited social contacts.…”

Section: Introductionmentioning

confidence: 99%

Systematic Review on the Mental Health and Treatment Impacts of COVID-19 on Neurocognitive Disorders

Dellazizzo

Léveillé

Landry

et al. 2021

JPM

View full text Add to dashboard Cite

Objectives. The COVID-19 pandemic has had many public health impacts, especially on vulnerable individuals including adults with neurocognitive disorders (NCD). With increasing literature, this systematic literature review aimed to address the mental health effects of COVID-19 on people with NCD in addition to examine the impact of the pandemic on treatments/resources for NCD. Methods. A literature search was conducted in the electronic databases of PubMed, PsycINFO, Web of Science and Google Scholar. Studies were included so long as they assessed the mental health or therapeutic effects of COVID-19 on NCD. Results. Among the retrieved articles, 59 met eligibility criteria. First, the pandemic and resulting self-isolation led to many detrimental effects on psychological well-being. Exacerbation and relapses of neurocognitive and behavioral symptoms were observed, as well as emergences of new psychological symptoms (i.e., depression, anxiety). Second, therapeutic and community services for individuals suffering from NCD, such as social support services and outpatient clinics, were disrupted or reduced leading to postponed appointments and evaluations, as well as reduced access to medications. These issues were somewhat palliated with the growth of telemedicine. Conclusion. This systematic review highlights the extent of the effects of the pandemic, and the topics addressed should be taken into consideration by healthcare practitioners, institutions, and policymakers to ensure that proper measures are employed to protect this population from additional harm.

show abstract

Managing medicines in the time of COVID-19: implications for community-dwelling people with dementia

Cited by 15 publications

References 18 publications

Impact of the COVID-19 Pandemic on Family Carers of Older People Living with Dementia in Italy and Hungary

Impact of the COVID-19 Pandemic on Family Carers of Older People Living with Dementia in Italy and Hungary

Neurological impairments in COVID-19 pandemic

Systematic Review on the Mental Health and Treatment Impacts of COVID-19 on Neurocognitive Disorders

Contact Info

Product

Resources

About